Opioid overdose reversal medicines like Narcan may soon be as standard-issue as fire extinguishers in affordable and public housing communities. The federal government urged housing providers to stock drugs like Narcan onsite in a joint letter signed by the White House Office of...

Overdose deaths among pregnant and postpartum women nearly tripled between 2018 and 2021, according to a study from the National Institutes of Health (NIH) published Wednesday. The rate of overdoses increased from 4.9 per 100,000 women between the ages 35-44 to 15.8 in 2021, the...

Tis the season for holiday celebrations and family gatherings; the season of gift-giving and champagne-toasting; the season in which many of us come together to ‘eat, drink, and be merry.’ Yet as fun and joyous as they can be, the holidays often commence a challenging time for...

At the University of North Carolina at Chapel Hill, three students stand behind a card table covered in naloxone injection kits. When a curious student leans in and asks what the kits are for, Caroline Clodfelter, one of the co-founders of the student group running the table,...

The number of drug overdose deaths in the United States is still increasing every month, according to new data, but the pace appears to be slowing.

Nearly three-quarters of the over 29 million adult Americans who identify as having substance use disorder are in recovery, new federal data shows. This weekend, hundreds of advocates in the field gathered in Washington, D.C. to call for political action and support for people...

During National Recovery Month, we celebrate the more than 20 million Americans who have had the courage to seek help for substance use disorder, showing millions of others that recovery is possible. We honor their resilience and recommit to making sure that every American has...

I’ve been living in recovery from opioid use disorder for eight and a half years, and this might be a weird thing to say about addiction, but I feel lucky—like I dodged a bullet. I was addicted to opioids in Florida throughout the early 2000s, during the heyday of pill mills...

The FDA also approved the first generic non-prescription naloxone drug in July 2023. The US Food and Drug Administration (FDA) approved the second over-the-counter (OTC) naloxone nasal spray product, RiVive (3mg) by non-profit pharmaceutical company Harm Reduction Therapeutics,...